Lipitor Again

Just before I get onto the motorway I should mention an article by Alex Benerson in today's New York Times entitled "Lipitor or Generic? Billion-Dollar Battle Looms" which provides more background information for the Ranbaxy case. The key point of the article is that "spending on prescription drugs has jumped from US$40 billion in 1990 to almost US$250 billion this year, and continues to rise faster than overall inflation." Interestingly, the article also reports resistance by doctors and patients to migrating from to a generic even after a patent expires.

It is necessary to register to access NYT articles. Registration is free. It's as well to move quickly, however, because the NYT charges for archived material.

Comments

Popular posts from this blog

Were we to go - what would Brexit mean for IP?

The Draft Patents (European Patent with Unitary Effect and Unified Patent Court) Order 2016

Supreme Court upholds Court of Appeal in Trunki